Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WW
WW logo

WW Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
11.110
Open
10.200
VWAP
10.34
Vol
327.65K
Mkt Cap
99.89M
Low
9.930
Amount
3.39M
EV/EBITDA(TTM)
7.86
Total Shares
10.00M
EV
446.56M
EV/OCF(TTM)
--
P/S(TTM)
0.15
WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.
Show More

Events Timeline

(ET)
2026-05-07
07:10:00
Company Reports Q1 Revenue of $168.26M, Beating Expectations
select
2026-05-07
07:10:00
Company Reaffirms FY26 Adjusted EBITDA Guidance of $105M to $115M
select
2026-04-27 (ET)
2026-04-27
16:20:00
Major Averages Close Mixed Amid Escalating Geopolitical Tensions
select
2026-04-27
12:00:00
Major Averages Decline Amid Stalled US-Iran Peace Talks
select
2026-04-27
10:30:00
WW International Plans to Prepay $40M in Loans
select
2026-04-27
10:30:00
WW International Shares Rise 22% to $11.31
select
2026-04-20 (ET)
2026-04-20
07:40:00
WW International Appoints Heather Thiltgen to Board of Directors
select
2026-04-06 (ET)
2026-04-06
16:40:00
Major Averages Rise as US-Iran Ceasefire Talks Emerge
select
2026-04-06
12:00:00
Major Averages Broadly Higher as U.S.-Iran War May End Soon
select

News

Newsfilter
7.5
05-01Newsfilter
Weight Watchers Launches Ozempic® Pill for Diabetes Care
  • New Drug Launch: Weight Watchers announced the addition of Novo Nordisk's Ozempic® pill through its Med+ program, further expanding its portfolio of oral GLP-1 treatments aimed at providing more options for adults with type 2 diabetes, thereby enhancing its competitive edge in the market.
  • Insurance Coverage Advantage: The widespread insurance coverage of Ozempic® allows eligible members to access monthly prescription costs as low as $25, which not only reduces the financial burden on patients but also increases Weight Watchers' appeal in the diabetes management sector.
  • Clinical Support System: The Weight Watchers Med+ program offers FDA-approved Ozempic® along with support from a professional clinical team, assisting members in navigating insurance and daily management, thus improving treatment outcomes.
  • Significant Health Outcomes: In a study of 136 participants, the Weight Watchers diabetes nutrition program resulted in a 0.75% reduction in HbA1c levels after six months, demonstrating the program's effectiveness in improving health for diabetes patients and further solidifying Weight Watchers' market position.
Yahoo Finance
4.5
04-28Yahoo Finance
U.S. Stocks Decline Amid Geopolitical Tensions and Earnings Strength
  • Geopolitical Tensions: Stalled peace negotiations between the U.S. and Iran have led to rising oil prices, raising fresh concerns about inflation and global economic growth, as investors balance strong corporate earnings against geopolitical uncertainties.
  • Earnings Performance: Verizon (VZ) reported a better-than-expected Q1, while Domino's Pizza (DPZ) posted disappointing results and announced an additional $1 billion share repurchase program, highlighting the varied market reactions to different companies.
  • Acquisition Activity: Shell (SHEL) agreed to acquire ARC Resources (AETUF) for C$32.80 per share, while China blocked Meta's (META) acquisition of AI startup Manus, reflecting the complexities of the global M&A landscape.
  • Market Index Fluctuations: Near midday, the Dow was down 0.25%, the Nasdaq down 0.28%, and the S&P 500 down 0.14%, indicating the market's sensitive response to geopolitical tensions and economic data.
stocktwits
9.5
04-27stocktwits
WW Plans to Prepay $40 Million Loan Ahead of Earnings Report
  • Debt Prepayment: WW plans to utilize up to $40 million in cash to prepay its outstanding term loan, thereby reducing its debt burden, and expects to generate cash flow during the 'peak season marketing,' enhancing the company's financial stability.
  • Q1 Expectations: Fiscal AI estimates a Q1 loss per share of $2.05 on revenue of $158.5 million, while full-year revenue is still projected between $620 million and $635 million, demonstrating the company's ability to maintain revenue stability amid challenges.
  • Leadership Changes: WW recently experienced the abrupt departure of CEO Tara Comonte, and while the company is still searching for a new CEO, this change may impact strategic execution and market confidence.
  • Retail Trader Reaction: On Stocktwits, retail sentiment about WW shifted from 'bullish' to 'extremely bullish,' with messaging volumes tripling over the last 24 hours, indicating a positive market response to the company's debt reduction efforts.
Newsfilter
8.5
04-27Newsfilter
Weight Watchers Plans to Prepay Term Loan with $40 Million
  • Loan Prepayment Plan: Weight Watchers announced its intention to utilize up to $40 million in cash to prepay its outstanding term loan, including $25 million to $30 million in annual cash sweep due June 24, 2026, which will enhance the company's liquidity and reduce financial costs.
  • Voluntary Prepayment Solicitation: The company also plans to solicit voluntary prepayment of up to $10 million in cash at a discount, expected to occur from April 27 to April 30, 2026, further optimizing its capital structure and financial flexibility.
  • Financial Guidance Reaffirmed: Weight Watchers reaffirmed its first quarter 2026 subscriber estimates and full-year financial guidance, indicating that after peak season marketing, the company expects to generate cash flow to support future investments and growth.
  • Strategic Priorities: The CFO stated that today's announcements reflect progress made over the past year in strengthening liquidity and deleveraging, emphasizing the company's commitment to ongoing investments in its integrated weight health ecosystem to drive sustainable, profitable growth.
moomoo
7.0
04-27moomoo
WW International Inc. Anticipates Cash Generation for Remainder of Year After Q1 Cash Expenditure for Peak Season Marketing
  • Cash Generation Expectations: International Inc. anticipates generating cash through the remainder of the year.

  • Q1 Cash Usage: The company experienced significant cash usage in the first quarter, attributed to peak season marketing efforts.

moomoo
7.0
04-27moomoo
WW International Inc. - Weight Watchers Confirms Q1 2026 Subscriber Projections and FY2026 Financial Outlook
  • Financial Guidance: International Inc. has reaffirmed its estimates for Q1 2026 and provided financial guidance for FY 2026.
  • Subscriber Estimates: The company has updated its subscriber estimates, indicating a focus on growth and market positioning.
Wall Street analysts forecast WW stock price to rise
1 Analyst Rating
Wall Street analysts forecast WW stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
38.00
Averages
38.00
High
38.00
Current: 0.000
sliders
Low
38.00
Averages
38.00
High
38.00
Morgan Stanley
Equal Weight
downgrade
$21 -> $20
AI Analysis
2026-05-08
New
Reason
Morgan Stanley
Price Target
$21 -> $20
AI Analysis
2026-05-08
New
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $20 from $21 and keeps an Equal Weight rating on the shares.
Morgan Stanley
Equal Weight
downgrade
$21
2026-04-01
Reason
Morgan Stanley
Price Target
$21
2026-04-01
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $21 from $34.50 and keeps an Equal Weight rating on the shares. A mix shift from behavioral to clinic is happening far faster than the firm anticipated, but this comes with upside as well as "negative trade-offs," the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WW
Unlock Now

Valuation Metrics

The current forward P/E ratio for WW International Inc (WW.O) is 74.07, compared to its 5-year average forward P/E of -8.36. For a more detailed relative valuation and DCF analysis to assess WW International Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-8.36
Current PE
74.07
Overvalued PE
146.01
Undervalued PE
-162.72

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
11.09
Current EV/EBITDA
8.22
Overvalued EV/EBITDA
15.19
Undervalued EV/EBITDA
6.98

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.54
Current PS
0.16
Overvalued PS
1.08
Undervalued PS
0.01

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

surging stocks between 10 to $20
Intellectia · 547 candidates
Price: $10.00 - $20.00Moving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
FSEA logo
FSEA
First Seacoast Bancorp Inc
78.21M
VRDN logo
VRDN
Viridian Therapeutics Inc
1.93B
BDSX logo
BDSX
Biodesix Inc
151.02M
AIOS logo
AIOS
AIOS Tech Inc
63.69M
ONEG logo
ONEG
OneConstruction Group Ltd
175.36M
IART logo
IART
Integra Lifesciences Holdings Corp
1.03B

Whales Holding WW

C
Contrarius Investment Management Ltd.
Holding
WW
+14.51%
3M Return
C
Cooper Creek Partners Management LLC
Holding
WW
+2.98%
3M Return
A
Aristeia Capital, LLC
Holding
WW
-4.90%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is WW International Inc (WW) stock price today?

The current price of WW is 9.99 USD — it has decreased -2.06

What is WW International Inc (WW)'s business?

WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.

What is the price predicton of WW Stock?

Wall Street analysts forecast WW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WW is38.00 USD with a low forecast of 38.00 USD and a high forecast of 38.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is WW International Inc (WW)'s revenue for the last quarter?

WW International Inc revenue for the last quarter amounts to 168.26M USD, decreased -9.81

What is WW International Inc (WW)'s earnings per share (EPS) for the last quarter?

WW International Inc. EPS for the last quarter amounts to -5.20 USD, increased 471.43

How many employees does WW International Inc (WW). have?

WW International Inc (WW) has 3500 emplpoyees as of May 12 2026.

What is WW International Inc (WW) market cap?

Today WW has the market capitalization of 99.89M USD.